HLB Life Science Co., Ltd. (KOSDAQ:067630)
South Korea · Delayed Price · Currency is KRW 2,405.00
-145.00 (-5.69%)
Sep 18, 2026, 3:30 PM KST
HLB Life Science Market Cap
HLB Life Science has a market cap or net worth of 293.04 billion as of September 18, 2026. Its market cap has decreased by -30.19% in one year.
Market Cap
293.04B
Enterprise Value
438.11B
Revenue
54.40B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,405.00
ChartMarket Cap Chart
Since November 25, 2008, HLB Life Science's market cap has increased from 12.28B to 293.04B, an increase of 2,285.81%. That is a compound annual growth rate of 19.48%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 293.04B | -37.94% |
| Dec 30, 2025 | 472.16B | -61.28% |
| Dec 30, 2024 | 1.22T | 4.61% |
| Dec 28, 2023 | 1.17T | 8.14% |
| Dec 29, 2022 | 1.08T | -9.34% |
| Dec 30, 2021 | 1.19T | -7.14% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 65.15T |
| Celltrion | 42.53T |
| ALTEOGEN | 17.79T |
| Samsung Epis Holdings | 8.12T |
| MEDIPOST | 338.87B |
| Dentium CO., LTD | 323.83B |
| Curexo | 321.83B |
| EuBiologics | 305.78B |